The week's investing action plan includes a strong dose of pharma and biotech earnings, January econ reports, plus Amazon and ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...

Detailed price information for Merck & Company (MRK-N) from The Globe and Mail including charting and trades.

Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 (£191.84) on Tuesday. A key focus in Amazon's ( AMZN) upcoming results will ...

Altria Group Inc. said it continues to face the challenge of counterfeit products in the rapidly growing vape market. But the company narrowly beat Wall Street's fourth-quarter earnings projections.

With new drug development, a significant increase in sales, and high potential with Mounjaro and Zepbound, here’s what we think of Eli Lilly’s stock ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

The global diabetic nephropathy market was valued at $1.9 billion in 2021, and is projected to reach $3.3 billion by 2031, growing at a CAGR of 6%.

The ClearBridge Large Cap Growth ESG Strategy underperformed its Russell 1000 Growth Index benchmark in the fourth quarter.

Seaport Res Ptn issued their Q1 2025 earnings estimates for shares of American Express in a report issued on Monday, January 27th. Seaport Res Ptn analyst W. Ryan forecasts that the payment services ...

When Merck reports fourth-quarter earnings, investors are likely to focus on the sales of its blockbuster oncology medicine, ...

Citi analyst Geoff Meacham lowered the firm’s price target on Eli Lilly to $1,190 from $1,250 and keeps a Buy rating on the shares. Ahead of ...